<unk>  is a non-competitive AMPA glutamate receptor antagonist that is FDA approved for the {{{indicationType}}} of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy aged 12 years and older. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include dizziness, somnolence, fatigue, irritability, falls, nausea, weight gain, vertigo, ataxia, gait disturbance, and balance disorder.
Perampanel
Guanabenz
Guanoxabenz
Lubeluzole
Methocarbamol 
Tirilazad
Tirapazamine
Carbidopa